Is UnitedHealth Group a Buy, Sell, or Hold in 2026?

UnitedHealth Group shows signs of turnaround with Q1 2026 results beating expectations, including 2% revenue growth and improved operating margins. The company cut Medicare Advantage membership by 1.3 million to address margin pressures from payment-cost disconnects. Analysts recommend the stock as a buy for long-term investors or a hold for those seeking dividend income, citing attractive valuation despite ongoing regulatory challenges.

05/13/2026, 5:15 AM • The Motley Fool

Global Healthcare Analytics Market is Predicted to Cross the USD 380 Billion Mark by 2034 | DelveInsight

The global healthcare analytics market is projected to grow from USD 56 billion in 2025 to USD 390 billion by 2034, with a CAGR of ~24%. Growth is driven by widespread EHR adoption, rising chronic disease prevalence, shift toward value-based care, AI/ML integration, and government digital health initiatives. North America leads with 44.36% market share, while Asia-Pacific emerges as a major growth engine.

05/06/2026, 1:00 PM • GlobeNewswire

Why UnitedHealth Group Stock Came Roaring Back In April

UnitedHealth Group stock surged 36.9% in April following better-than-expected Q1 earnings and improved guidance. The company's medical loss ratio improved to 83.9% from 84.8% year-over-year, signaling recovery from healthcare cost pressures. With management raising EPS guidance and potential margin expansion ahead, the stock appears undervalued at a forward P/E of 20.

05/05/2026, 6:22 PM • The Motley Fool

Is UnitedHealth Stock a Generational Buying Opportunity?

UnitedHealth faced profit collapse due to underestimated costs but is now incorporating artificial intelligence to improve operations. The article explores whether the stock presents a buying opportunity following recent challenges.

05/05/2026, 4:15 AM • The Motley Fool

Is UnitedHealth Stock an Undervalued Stock to Buy?

UnitedHealth (UNH) stock investors are hoping 2026 will be better than 2025. The article discusses whether UnitedHealth represents an undervalued buying opportunity, noting some positive developments in the company's latest investor update. The stock has shown significant gains recently, up more than 30% in one month, and offers a 2.5% dividend yield.

05/01/2026, 11:13 PM • The Motley Fool

Want to Build Real Wealth in Healthcare? These Stocks Are Worth Considering

The article recommends three healthcare stocks for building long-term wealth: Johnson & Johnson, which is focusing on pharmaceuticals and medtech with strong sales growth and a 64-year dividend history; Vertex Pharmaceuticals, a leader in cystic fibrosis treatments with successful expansion into other areas; and UnitedHealth Group, which is recovering from previous challenges through better pricing, operational improvements, and AI efficiency gains.

04/30/2026, 6:10 AM • The Motley Fool

UnitedHealth Stock Is Up More Than 30% in 1 Month and Pays a 2.5% Dividend Yield. Time to Buy?

UnitedHealth's stock has surged 30% in one month following strong Q1 2026 earnings that showed improved medical care ratios and raised full-year guidance to over $18.25 adjusted EPS. While the company demonstrated operational progress with better cost management and margin expansion in its UnitedHealthcare segment, the author argues the stock's recent rally has fully priced in these improvements. At 19x forward earnings and facing headwinds like Medicare Advantage membership declines and weaker Optum performance, the author recommends staying on the sidelines rather than buying at current valuations.

04/24/2026, 5:23 PM • The Motley Fool

UnitedHealth Just Proved Warren Buffett Right -- Again

Warren Buffett's $1.6 billion investment in UnitedHealth Group last year during the company's troubles has proven prescient. UnitedHealth's Q1 2026 results show a turnaround with improved medical cost ratios due to rate increases, better-than-expected earnings, and raised full-year guidance. The results validate Buffett's strategy of buying quality businesses at discounted prices and holding through temporary challenges.

04/23/2026, 4:44 AM • The Motley Fool

What's Going On With UnitedHealth Stock On Wednesday?

UnitedHealth Group raised its 2026 earnings guidance to over $18.25 per share after beating Q1 expectations with adjusted earnings of $7.23 versus consensus of $6.58. The stock is up 3.20% but shows overbought conditions with RSI at 80.86. The company highlighted challenges with the Medicare BALANCE obesity drug coverage program, though it maintains a Buy rating with an average price target of $380.38.

04/22/2026, 11:24 AM • Benzinga

Stock Market Today, April 21: Markets in Wait-and-See Mode as Hopes for New U.S.-Iran Peace Talks Fade

Major U.S. stock indices declined on April 21, 2026, as geopolitical uncertainty over U.S.-Iran tensions and restricted Strait of Hormuz traffic weighed on sentiment. The S&P 500, Nasdaq, and Dow Jones each fell approximately 0.6%. UnitedHealth Group surged on strong earnings, while defense stocks GE Aerospace and RTX declined despite beating estimates. Apple and Tesla also fell amid leadership transition news and pre-earnings uncertainty.

04/21/2026, 6:01 PM • The Motley Fool

S&P 500 Eases On Iran Ceasefire Jitters, Crude Soars To $90: Stock Market Today

U.S. equities drifted lower midday Tuesday as the S&P 500 slipped 0.3% and crude oil surged 2.7% to $90/barrel amid uncertainty over Iran peace talks. Rising Treasury yields and geopolitical tensions weighed on markets, with energy stocks leading gains while gold miners and airlines faced sharp declines. Strong retail sales and ADP payroll data underscored consumer resilience but fueled rate hike concerns.

04/21/2026, 2:47 PM • Benzinga

UnitedHealth Stock Jumps After Q1 Beat — Here's What Execs Say Drove It

UnitedHealth Group (UNH) shares surged 8.51% after delivering a strong Q1 earnings beat with adjusted EPS of $7.23 versus consensus of $6.58, and revenue of $111.7 billion. The company raised its full-year 2026 EPS guidance to greater than $18.25 from $17.75, citing improved medical cost trends, operational efficiencies in its Optum Health division, and accelerated $2 billion share buybacks. Management attributed gains to disciplined pricing, reduced hospital admissions, and AI investments, though cautioned that Q2 results will be key to validating the full-year outlook.

04/21/2026, 2:39 PM • Benzinga

UnitedHealth: A Healthy Rebound Could Lie Ahead for Shareholders

UnitedHealth (UNH) demonstrated strong Q1 2026 earnings that beat consensus forecasts and provided improved guidance, reinstating $2 billion in share buybacks. The company's balance sheet improved following the divestiture of its Optum UK business, with reduced debt and increased equity. Analysts have signaled the bottom in UNH stock decline, and institutional investors have been accumulating shares aggressively. The stock faces a technical resistance hurdle at approximately $365, but could potentially rise 50% in the near-to-mid term if it breaks through this level.

04/21/2026, 1:17 PM • Investing

UnitedHealth Raises Profit Outlook As Medical Costs Ease

UnitedHealth Group reported first-quarter 2026 adjusted earnings of $7.23, beating consensus estimates of $6.58, with revenues of $111.721 billion. The company raised its fiscal 2026 adjusted earnings per share guidance to more than $18.25 from over $17.75. Medical cost ratios improved significantly, declining 90 basis points year-over-year to 83.9%. UnitedHealth also announced the acquisition of Alegeus Technologies and a $2 billion stock buyback program.

04/21/2026, 8:47 AM • Benzinga

Stock Market Today: Dow Jones, S&P 500 Futures Edge Higher With Eyes On Iran Talks—Apple, UnitedHealth, 3M In Focus

U.S. stock futures rose on Tuesday following Monday's decline, with major indices edging higher. Markets are focused on U.S.-Iran negotiations in Islamabad and Kevin Warsh's Fed Chair confirmation hearing. Key stocks in focus include Apple (CEO transition), UnitedHealth (earnings expected), 3M (earnings expected), Amazon (Anthropic partnership expansion), and Spruce Biosciences (stock offering announcement).

04/21/2026, 5:15 AM • Benzinga